News

MedPage Today5d
Ranibizumab Ocular Implant Shows Long-Term Benefits in Retinal Disease
The ranibizumab ocular implant (Susvimo) reduces the need for frequent intravitreal anti-VEGF injections in patients with ...
Ophthalmology Times5d
Q&A: David S. Boyer, MD, on the suprachordial delivery of gene therapy
Boyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, ...
The Cardiology Advisor6d
Susvimo Approved for Patients With Diabetic Retinopathy
The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...
Drug Delivery Business7d
Gore launches new plunger for prefilled syringes
The new offering, designed specifically for prefilled syringes used in various applications, complements its 1 mL ImProject ...
Ophthalmology Times12d
Q&A: Sunir Garg, MD, shares insights on using chlorhexidine for anti-sepsis
Sunir Garg, MD, discusses a challenge in ophthalmological procedures: patient discomfort during intravitreal injections ...
FDA approves Roche's Susvimo for diabetic retinopathy
Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine monthsSusvimo's innovative technology via the Port ...
Medical Xpress1mon
Intraocular inflammation more common with aflibercept injections in real-world setting
Karoline E. Binder, M.D., from the Technical University of Munich, and colleagues assessed the incidence of IOI after intravitreal injection of aflibercept, 8 mg, in real-world practice. The ...